These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 32813895

  • 21. Prognostic significance of body mass index-adjusted criteria for left ventricular hypertrophy.
    Afify H, Lee HL, Soliman EZ, Singleton MJ.
    J Clin Hypertens (Greenwich); 2020 Aug; 22(8):1476-1483. PubMed ID: 32762125
    [Abstract] [Full Text] [Related]

  • 22. Relationship of left ventricular systolic function to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new heart failure.
    Okin PM, Wachtell K, Gerdts E, Dahlöf B, Devereux RB.
    J Hypertens; 2014 Dec; 32(12):2472-8; discussion 2478. PubMed ID: 25340854
    [Abstract] [Full Text] [Related]

  • 23. Accuracy and prognostic significance of electrocardiographic markers of left ventricular hypertrophy in a general population: findings from the Pressioni Arteriose Monitorate E Loro Associazioni population.
    Cuspidi C, Facchetti R, Bombelli M, Sala C, Grassi G, Mancia G.
    J Hypertens; 2014 Apr; 32(4):921-8. PubMed ID: 24406778
    [Abstract] [Full Text] [Related]

  • 24. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men.
    Sundström J, Lind L, Arnlöv J, Zethelius B, Andrén B, Lithell HO.
    Circulation; 2001 May 15; 103(19):2346-51. PubMed ID: 11352882
    [Abstract] [Full Text] [Related]

  • 25. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S, Dohi Y, Higashi A, Kinoshita H, Sada Y, Hidaka T, Kurisu S, Shiode N, Kihara Y, HERO (Hiroshima Heart Study Group) Investigators.
    Heart Vessels; 2016 Sep 15; 31(9):1497-503. PubMed ID: 26531830
    [Abstract] [Full Text] [Related]

  • 26. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.
    Greve AM, Boman K, Gohlke-Baerwolf C, Kesäniemi YA, Nienaber C, Ray S, Egstrup K, Rossebø AB, Devereux RB, Køber L, Willenheimer R, Wachtell K.
    Circulation; 2012 Jan 17; 125(2):346-53. PubMed ID: 22147903
    [Abstract] [Full Text] [Related]

  • 27. Correlation between Echocardiographic Left Ventricular Hypertrophy and various Electrocardiographic Criteria of Left Ventricular Hypertrophy among Black Hypertensives.
    Ngabea MA, Ojji DB, Sani MU, Isezuo SA.
    West Afr J Med; 2021 Jul 29; 38(7):695-700. PubMed ID: 34331528
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. QT peak prolongation is not associated with left ventricular hypertrophy in teenage professional football players.
    Alchaghouri S, Wong KY, Perry RA, Ramsdale DR, Somauroo JD, Pyatt JR.
    Ann Noninvasive Electrocardiol; 2007 Apr 29; 12(2):104-10. PubMed ID: 17593178
    [Abstract] [Full Text] [Related]

  • 35. Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation.
    Okin PM, Gerdts E, Wachtell K, Oikarinen L, Nieminen MS, Dahlöf B, Devereux RB.
    J Hypertens; 2010 Jul 29; 28(7):1534-40. PubMed ID: 20589977
    [Abstract] [Full Text] [Related]

  • 36. Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients.
    Ishikawa J, Yamanaka Y, Toba A, Watanabe S, Harada K.
    Int Heart J; 2017 Dec 12; 58(6):933-938. PubMed ID: 29162779
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Competing cardiovascular outcomes associated with electrocardiographic left ventricular hypertrophy: the Atherosclerosis Risk in Communities Study.
    Desai CS, Ning H, Lloyd-Jones DM.
    Heart; 2012 Feb 12; 98(4):330-4. PubMed ID: 22139711
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Gender differences in regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy.
    Okin PM, Gerdts E, Kjeldsen SE, Julius S, Edelman JM, Dahlöf B, Devereux RB, Losartan Intervention for Endpoint Reduction in Hypertension Study Investigators.
    Hypertension; 2008 Jul 12; 52(1):100-6. PubMed ID: 18504323
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.